Congress quietly extends tick-disease research funding for five more years
H.R. 4348 — To reauthorize the Kay Hagan Tick Act, and for other purposes. · Filed by Chris Smith (R-NJ) · 36 cosponsors · Introduced Jul 10, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill extends federal funding and programs for tick-borne disease research and prevention for five more years (2026–2030), replacing the expiring 2021–2025 authorization. It updates the governance structure of the national strategy by clarifying which officials participate and expands the scope of regional centers to include capacity-building for disease identification, reporting, prevention, and response.
Why we flagged it
The bill is a routine extension of existing federal vector-borne disease programs. It contains no new policy, no private carve-outs, and no controversial provisions—only a five-year renewal of funding authority and minor administrative clarifications to the governance structure.
What the text implies
- The bill updates the reference from the Tick-Borne Disease Working Group (established under the 21st Century Cures Act) to the statutory citation (42 U.S.C. § 284s), which may reflect a structural reorganization of that working group but does not change its function or authority.
- Expansion of regional centers' scope to explicitly include 'capacity to identify, report, prevent, and respond' may enable broader surveillance and response infrastructure, potentially increasing federal coordination with state and local health departments.
Who stands to gain
state and local health departments; academic medical centers and research institutions receiving grants for vector-borne disease researc